Article No
OPCA335979-100
NCBI Number | 43740568 |
Article No | OPCA335979-100 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL, RU |
Description | Recombinant SARS-CoV-2 Spike Glycoprotein |
Supplier | Aviva Systems Biology |
Alias Names | SARS-CoV-2 S1-RBD protein, NCP-CoV RBD Protein, novel coronavirus RBD Protein, 2019-nCoV RBD Protein, S glycoprotein Subunit1 RBD Protein, COVID-19 |
Product Type | Proteins & Peptides |
Purity | Greater than 85% as determined by SDS-PAGE. |
Research Area | Virology, Microbiology |
Sequence | Partial Length (319-541aa): RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF |
Size | 100 ug |
Source / Host | virus |
Storage | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference. |
Substrate / Buffer | Lyophilized from Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
Product Page Updated | 2021-03-08T08:29:25.844Z |